Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 116

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 116
---
 sales of shares or the mere existence of our arrangement with Yorkville may make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect such sales.

| 63 |

Because the per share purchase price that Yorkville will pay for Advance Shares pursuant to any Advance that we may elect to effect pursuant to the SEPA will be determined by reference to the VWAP during the applicable period for such Advance on the applicable Purchase Date for such Advance, as of the date of this prospectus, we cannot determine the actual purchase price per share that Yorkville will be required to pay for any Advance Shares that we may elect to sell to Yorkville under the SEPA from and after the Commencement Date and, therefore, we cannot be certain how many Advance Shares, in the aggregate, we may issue and sell to Yorkville under the SEPA from and after the Commencement Date.

As of November 25, 2025, there were 34,426,355 shares of our common stock outstanding, which includes the 131,909 Commitment Shares that were issued to Yorkville on October 24, 2025 and of which 9,394,341 shares were held by non-affiliates of our company. If all of the 10,000,000 shares offered for resale by Yorkville under this prospectus were issued and outstanding as of the date hereof, such shares would represent approximately 29.0% of the total number of outstanding shares of common stock and approximately 106.5% of the total number of outstanding shares of common stock held by non-affiliates of our company, in each case as of November 25, 2025.

Although the SEPA provides that we may sell up to $20.0 million of our common stock to Yorkville, only (i) 131,909 Commitment Shares, (ii) up to 4,000,000 Conversion Shares and (iii) up to 5,868,091 Advance Shares are being registered under the Securities Act for resale by Yorkville under the initial Registration Statement that includes this prospectus. The Commitment Shares were issued to Yorkville on October 24, 2025. If we were to issue all of the Conversion Shares pursuant to the Fixed Price per share of $1.50 (without taking into account the 19.99% Exchange Cap limitation or the 4.99% Beneficial Ownership Limitation), such Conversion Shares